##gff-version 3
##sequence-region Q8TAP9 1 179
Q8TAP9	UniProtKB	Chain	1	179	.	.	.	ID=PRO_0000065674;Note=M-phase-specific PLK1-interacting protein	
Q8TAP9	UniProtKB	Modified residue	37	37	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9D011	
Q8TAP9	UniProtKB	Modified residue	40	40	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8TAP9	UniProtKB	Modified residue	47	47	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q8TAP9	UniProtKB	Modified residue	51	51	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q8TAP9	UniProtKB	Modified residue	57	57	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q8TAP9	UniProtKB	Modified residue	59	59	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q8TAP9	UniProtKB	Modified residue	68	68	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q8TAP9	UniProtKB	Modified residue	72	72	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:20068231;Dbxref=PMID:18691976,PMID:20068231	
Q8TAP9	UniProtKB	Modified residue	77	77	.	.	.	Note=Asymmetric dimethylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q8TAP9	UniProtKB	Modified residue	80	80	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163	
Q8TAP9	UniProtKB	Modified residue	82	82	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q8TAP9	UniProtKB	Modified residue	93	93	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000269|PubMed:17310276;Dbxref=PMID:18669648,PMID:17310276	
Q8TAP9	UniProtKB	Modified residue	104	104	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000269|PubMed:17310276;Dbxref=PMID:18669648,PMID:17310276	
Q8TAP9	UniProtKB	Modified residue	115	115	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8TAP9	UniProtKB	Modified residue	117	117	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q8TAP9	UniProtKB	Modified residue	120	120	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q8TAP9	UniProtKB	Modified residue	124	124	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q8TAP9	UniProtKB	Modified residue	133	133	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:20068231;Dbxref=PMID:17081983,PMID:18691976,PMID:20068231	
Q8TAP9	UniProtKB	Natural variant	29	29	.	.	.	ID=VAR_036273;Note=In a breast cancer sample%3B somatic mutation. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs565833937,PMID:16959974	
Q8TAP9	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_022940;Note=In TTD4. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15645389;Dbxref=dbSNP:rs137853117,PMID:15645389	
Q8TAP9	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Partially prevents phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17310276;Dbxref=PMID:17310276	
Q8TAP9	UniProtKB	Mutagenesis	104	104	.	.	.	Note=Has no effect on interaction with PLK1 in mitosis. Partially prevents phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17310276;Dbxref=PMID:17310276	
Q8TAP9	UniProtKB	Mutagenesis	120	120	.	.	.	Note=Abolishes interaction with PLK1 in mitosis. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17310276;Dbxref=PMID:17310276	
